The improvement of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various methods are employed, including protein engineering of the host cells and optimization of culture conditions. Furthermore, integration of advanced bioreactors can significan